Already a Bloomberg.com user?
Sign in with the same account.
SINPHAR PHARMA said unconsolidated sales in February rose 25.41% to NT$123,186,000 from NT$98,228,000, according to a statement filed to the Taiwan Stock Exchange.
(Figures are in thousands of New Taiwan dollars)
2/2012 2/2011 Sales 123,186 98,228 YOY% 25.41%
-----------------Year-to-date----------------- Sales 244,302 259,046 YOY% -5.69% =================================================================